Zymeworks is a clinical-stage biotechnology company united in creating disruptive therapeutic platforms and impactful biotherapeutics that return patients to their loved ones, disease free.
For Patients
Powerful, versatile protein engineering platforms for highly customized therapeutics including cytotoxic anti-tumor biologics, antibody drug conjugates, and immuno-oncology therapies.
Explore Platforms 
by creating tailored multifunctional therapeutics that enable enhanced efficacy and new biological approaches for treating diseases
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies.
using precise antibody Fc modifications that tailor the antibody-mediated immune response
in a single, transferable, conditionally active design
Zymeworks employees
